Trial Profile
Clinical Trials Insight: 700015297
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2010
Price :
$35
*
At a glance
- Drugs ZT 031 (Primary)
- Indications Osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Nektar Therapeutics
- 19 Sep 2007 Data presented at ASBMR by Zelos.
- 27 Sep 2006 New trial record.